Rapport Therapeutics Inc
(RAPP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | NRIX | GLUE | ||
| Company | Rapport Therapeutics Inc | Nurix Therapeutics Inc | Monte Rosa Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.70 | 16.78 | 19.43 | ||
| High | 27.21 | 16.89 | 19.83 | ||
| Low | 25.78 | 16.37 | 18.91 | ||
| Latest | 26.87 | 16.65 | 19.85 | ||
| Change | -0.22 | -0.20 | +0.30 | ||
| % Change | -0.81% | -1.19% | +1.53% | ||
| Volume | 61,683 | 247,590 | 591,760 | ||
| 20-Day Average Volume | 326,174 | 1,160,097 | 1,225,728 | ||
| Previous Close | 27.09 | 16.85 | 19.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.87 | 17.99 | 22.11 | ||
| 20-Day Raw Stochastic | 47.49% | 20.19% | 14.57% | ||
| 20-Day Relative Strength | 48.42 | 45.95 | 50.05 | ||
| Weighted Alpha | +15.65 | +5.69 | +126.48 | ||
| Today's Opinion | 24% Buy | 40% Buy | 80% Buy | ||
| Previous Opinion | 24% Buy | 40% Buy | 80% Buy | ||
| Last Month's Opinion | 80% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.67% since 02/02/26 | -2.05% since 02/02/26 | -5.17% since 02/02/26 | ||
| Low | 25.21 on 02/05/26 | 15.87 on 02/05/26 | 18.85 on 02/05/26 | ||
| High | 28.59 on 02/03/26 | 17.50 on 02/03/26 | 21.69 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | -6.73% since 01/09/26 | -13.26% since 01/09/26 | -18.45% since 01/09/26 | ||
| Low | 25.21 on 02/05/26 | 15.87 on 02/05/26 | 18.85 on 02/05/26 | ||
| High | 29.00 on 01/12/26 | 20.18 on 01/22/26 | 25.35 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +5.26% since 11/07/25 | +35.99% since 11/07/25 | +60.84% since 11/07/25 | ||
| Low | 23.75 on 11/17/25 | 12.01 on 11/13/25 | 12.40 on 11/10/25 | ||
| High | 32.36 on 12/23/25 | 22.50 on 12/08/25 | 25.77 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +85.64% since 08/08/25 | +70.12% since 08/08/25 | +352.05% since 08/08/25 | ||
| Low | 13.86 on 08/19/25 | 8.19 on 09/23/25 | 4.15 on 08/11/25 | ||
| High | 42.27 on 09/08/25 | 22.50 on 12/08/25 | 25.77 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,291,136 | 1,295,479 | 1,273,057 | ||
| Shares Outstanding, K | 47,661 | 76,883 | 65,118 | ||
| Annual Sales | 0 | 83,980,000 | 75,620,000 | ||
| Annual Net Income | -78,310,000 | -264,460,000 | -72,700,000 | ||
| Last Quarter Sales | 0 | 13,580,000 | 12,770,000 | ||
| Last Quarter Net Income | -26,930,000 | -78,220,000 | -27,080,000 | ||
| 60-Month Beta | 1.63 | 1.96 | 1.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 11/06/25 | -1.03 on 10/09/25 | -0.33 on 11/06/25 | ||
| Latest Earnings Date | 03/10/26 | 04/14/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 59.06 | ||